⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INDP News
Indaptus Therapeutics, Inc. Common Stock
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
globenewswire.com
INDP
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
globenewswire.com
INDP
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
INDP